Cervical Cancer and Human Papillomavirus (HPV)

Cervical cancer is a malignancy of the uterine cervix that is caused, in the great majority of cases, by persistent infection with high-risk types of human papillomavirus (HPV). Because it has a known viral cause and a long, detectable precursor phase, it is one of the most preventable cancers through vaccination and screening.

Definition

Cervical cancer is an invasive malignant neoplasm of the cervix uteri, most commonly squamous cell carcinoma or adenocarcinoma, arising from precursor intraepithelial lesions driven by persistent high-risk HPV infection.

Scope

This entry covers the natural history of cervical carcinogenesis from HPV infection through precancerous lesions to invasive cancer, the role of high-risk HPV types, the evidence that HPV is a necessary cause, and the principles of prevention by vaccination and screening. It treats the disease as a reference topic and does not provide individualized clinical management advice.

Core questions

• How does persistent high-risk HPV infection lead to cervical precancer and invasive cancer?
• What is the evidence that HPV is a necessary cause of cervical cancer?
• How do HPV vaccination and cervical screening interrupt the carcinogenic pathway?
• Why does cervical cancer burden fall disproportionately on low- and middle-income countries?

Key concepts

• High-risk HPV genotypes (e.g., HPV-16, HPV-18)
• Persistent infection and viral integration
• Cervical intraepithelial neoplasia (precursor lesions)
• Squamous cell carcinoma and adenocarcinoma
• Necessary-cause model of carcinogenesis
• Prophylactic HPV vaccination
• Transformation zone of the cervix

Mechanisms

Cervical cancer develops through a well-characterized sequence: high-risk HPV infects basal epithelial cells of the cervical transformation zone; most infections clear, but persistent infection can lead to precancerous intraepithelial lesions and, over years, to invasive cancer. The viral oncoproteins E6 and E7 inactivate the tumor-suppressor pathways governed by p53 and Rb, driving genomic instability and malignant transformation. Walboomers and colleagues (1999) demonstrated HPV DNA in virtually all invasive cervical cancers, establishing HPV as a necessary cause; Schiffman and colleagues (2007) synthesized the natural-history model that underlies modern prevention.

Clinical relevance

Because cervical cancer has a viral cause and a long precursor phase, it is uniquely amenable to primary prevention (HPV vaccination) and secondary prevention (screening and treatment of precancer). This entry explains why those strategies work mechanistically; it is educational and does not substitute for clinical evaluation or individualized care.

Epidemiology

Cervical cancer is among the most common cancers in women worldwide and a leading cause of cancer death in many low- and middle-income countries, where access to vaccination and screening is limited; Arbyn and colleagues (2020) estimated the global incidence and mortality and documented striking geographic disparities. In settings with organized screening and vaccination, incidence has fallen substantially. Population-level cohort data show that HPV vaccination markedly reduces the risk of invasive cervical cancer, particularly when given before exposure (Lei, 2020).

History

Harald zur Hausen's hypothesis that HPV causes cervical cancer, advanced in the 1970s-1980s, reframed the disease and was later recognized with a Nobel Prize. The causal model was solidified by epidemiologic studies showing HPV DNA in essentially all cervical cancers (Walboomers, 1999), and by the synthesis of natural history into a prevention framework (Schiffman, 2007). Randomized trials of prophylactic HPV vaccines followed (Garland, 2007), and population data later confirmed real-world cancer prevention (Lei, 2020).

Debates

Primary HPV testing versus cytology as the basis of screening

Programs have shifted toward primary high-risk HPV testing because of its greater sensitivity for precancer, but questions remain about optimal screening intervals, triage of HPV-positive results, and implementation in low-resource settings.

Key figures

• Harald zur Hausen
• Jan Walboomers
• Chris Meijer
• Mark Schiffman

Seminal works

• walboomers-1999
• schiffman-2007
• garland-2007
• lei-2020

Frequently asked questions

Is HPV the only cause of cervical cancer?

Persistent infection with high-risk HPV is considered a necessary cause of essentially all cervical cancers; cofactors such as smoking and immunosuppression can influence progression, but cancer rarely develops without HPV.

Can cervical cancer be prevented?

Yes — it is one of the most preventable cancers. Prophylactic HPV vaccination reduces infection with cancer-causing types, and screening detects and allows treatment of precancerous lesions before they become invasive.